Brief: Aziyo Biologics Posts Q4 Loss Of $0.38 Per Share

Elutia

22/03/2023 20:03

March 22 (Reuters) - Aziyo Biologics Inc  AZYO.O :
    * AZIYO BIOLOGICS REPORTS RECORD FULL YEAR 2022 REVENUES
    * Q4 2022 NET SALES OF $12.7 MILLION, REPRESENTING AN
INCREASE OF
17% IN Q4 2022 COMPARED TO Q4 2021
    * QTRLY LOSS PER SHARE $0.38
    * Q4 EARNINGS PER SHARE VIEW $-0.69, REVENUE VIEW $12.6
MILLION --
REFINITIV IBES DATA

Source text for Eikon:  ID:nGNXc6JBsW 
Further company coverage:  AZYO.O 

 ((Reuters.Briefs@thomsonreuters.com;))